Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) for Transplantation in Pediatric and Adult Patients With Hematologic Malignancies and Other Indications

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT01351545
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:27:56.888790+00:00
Published At
2026-04-13T00:00:00+00:00
Record Updated At
2026-04-13
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Hematologic Malignancies", "Inherited Disorders of Metabolism", "Inherited Abnormalities of Platelets", "Histiocytic Disorders", "Acute Myelogenous Leukemia (AML or ANLL)", "Acute Lymphoblastic Leukemia (ALL)", "Other Acute Leukemia", "Chronic Myelogenous Leukemia (CML)", "Myelodysplastic (MDS) / Myeloproliferative (MPN) Diseases", "Other Leukemia", "Hodgkin Lymphoma", "Non-hodgkin Lymphoma", "Multiple Myeloma/ Plasma Cell Disorder (PCD)", "Inherited Abnormalities of Erythrocyte Differentiation or Function", "Disorders of the Immune System", "Autoimmune Diseases", "Severe Aplastic Anemia"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-04-13"
protocolSection.identificationModule.nctId
"NCT01351545"
protocolSection.identificationModule.officialTitle
"A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) for Transplantation in Pediatric and Adult Patients With Hematologic Malignancies and Other Indications"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
[]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Hematologic Malignancies (protocolSection.conditionsModule.conditions)
  • Inherited Disorders of Metabolism (protocolSection.conditionsModule.conditions)
  • Inherited Abnormalities of Platelets (protocolSection.conditionsModule.conditions)
  • Histiocytic Disorders (protocolSection.conditionsModule.conditions)
  • Acute Myelogenous Leukemia (AML or ANLL) (protocolSection.conditionsModule.conditions)
  • Acute Lymphoblastic Leukemia (ALL) (protocolSection.conditionsModule.conditions)
  • Other Acute Leukemia (protocolSection.conditionsModule.conditions)
  • Chronic Myelogenous Leukemia (CML) (protocolSection.conditionsModule.conditions)
  • Myelodysplastic (MDS) / Myeloproliferative (MPN) Diseases (protocolSection.conditionsModule.conditions)
  • Other Leukemia (protocolSection.conditionsModule.conditions)
  • Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
  • Non-hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
  • Multiple Myeloma/ Plasma Cell Disorder (PCD) (protocolSection.conditionsModule.conditions)
  • Inherited Abnormalities of Erythrocyte Differentiation or Function (protocolSection.conditionsModule.conditions)
  • Disorders of the Immune System (protocolSection.conditionsModule.conditions)
  • Autoimmune Diseases (protocolSection.conditionsModule.conditions)
  • Severe Aplastic Anemia (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.